Nuveen Asset Management, LLC Hille Vax, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$11.86 - $15.93 $1.06 Million - $1.42 Million	89,303 Added 184.47%	137,713 $1.99 Million
Q4 2023 Feb 14, 2024	BUY	$10.35 - $17.11 $91,059 - $150,533	8,798 Added 22.21%	48,410 $776,000
Q3 2023 Nov 14, 2023	SELL	$11.59 - $16.7 $4,126 - $5,945	-356 Reduced 0.89%	39,612 $532,000
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.76 $207,733 - $301,398	16,066 Added 67.22%	39,968 $687,000
Q4 2022 Feb 14, 2023	BUY	$13.52 - $21.46 $74,806 - $118,738	5,533 Added 30.12%	23,902 $400,000
Q2 2022 Aug 15, 2022	BUY	$8.7 - $20.18 $159,810 - $370,686	18,369 New	18,369 $201,000

36.8M

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $65.5M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.